date:Sep 10, 2013
on will be used to reduce debt and for general corporate purposes
Lucozade and Ribena are iconic brands that have made a huge contribution to GSK over the years, said David Redfern, Chief Strategy Officer of GSK, Now is the right time to sell them as we increase the focus of our Consumer Healthcare business and execute the delivery of our late stage pipeline of pharmaceuticals and vaccines.
SBF, a leading global soft drink company headquartered in Japan, will acquire global rights to the brand